Simvastatin & Docetaxel?: New cell... - Advanced Prostate...

Advanced Prostate Cancer

21,806 members27,289 posts

Simvastatin & Docetaxel?

pjoshea13 profile image
3 Replies

New cell study below.

Bottom line: Simvastatin might enhance Taxotere killing potential.

-Patrick

ncbi.nlm.nih.gov/pubmed/288...

BMB Rep. 2017 Aug 11. pii: 3861. [Epub ahead of print]

Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.

Jung EJ, Chung KH, Kim CW1.

Author information

Abstract

In this study, our results showed that the c-Jun N-terminal kinase (JNK) activation was associated with the enhancement of docetaxel-induced cytotoxicity by simvastatin in DU145 human prostate cancer cells. To better understand the basic molecular mechanisms, we investigated simvastatin-regulated targets during simvastatin-induced cell death in DU145 cells using two-dimensional (2D) proteomic analysis. Thus, vimentin, Ras-related protein Rab-1B (RAB1B), cytoplasmic hydroxymethylglutaryl-CoA synthase (cHMGCS), thioredoxin domain-containing protein 5 (TXNDC5), heterogeneous nuclear ribonucleoprotein K (hnRNP K), N-myc downstream-regulated gene 1 (NDRG1) and isopentenyl-diphosphate Delta-isomerase 1 (IDI1) protein spots were identified as simvastatin-regulated targets involved in DU145 cell death signaling pathways. Moreover, the upregulation of NDRG1 and IDI protein levels by combination treatment of docetaxel and simvastatin was significantly inhibited by the JNK inhibitor SP600125. These results suggest that, at least, NDRG1 and IDI could play an important role in DU145 cell death signaling as simvastatin-regulated targets associated with JNK activation.

PMID: 28803608

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
3 Replies

I wonder if other statins would have a similar benefit. Simvastatin severely aggravates my GERD / Reflux. I had to switch to atorvastatin.

pjoshea13 profile image
pjoshea13 in reply to

In general, it is the lipophilic statins that show benefit in PCa:

"Atorvastatin, lovastatin, and simvastatin are lipophilic, whereas pravastatin, rosuvastatin, and fluvastatin are more hydrophilic." [MedScape]

Whether Atorvastatin (or Lovastatin) would perform as well as Simvastatin in the Docetaxel study, I can't say. But the authors make no special claim for Simvastatin in the Abstract.

-Patrick

BigRich profile image
BigRich

Lipophilic statins such as Simvastatin may also increase the duration for Zytiga. Recent research study from Dana Farber and John Hopkins.

Rich

Not what you're looking for?

You may also like...

USPSTF Update 2024

Over 6 years later the USPSTF has yet to update the screening guidelines and we're seeing more and...

Have you done Cabazitaxel before Docetaxel?

If you did Cabazitaxel before docetaxel, then let me know what your experience was like. I know...

List of drugs by their metastatic prostate cancer cancer fighting properties

I asked ChatGPT to put the following drugs in order of their metastatic prostate cancer cancer...

Prostrate cell division

Does age effect the speed at which prostate cancer cells divide? There are many factors that affect...

pluvicto + docetaxel

Disclosures: I am not a doctor or a medical advisor. My views are personal, and I post them here...